XML 23 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity and Earnings per Share
9 Months Ended
Jun. 30, 2018
Equity [Abstract]  
Stockholders' Equity and Earnings per Share
Stockholders’ Equity and Earnings per Share
 
In November 2017, the Company’s board of directors increased the quarterly cash dividend by 4% from $0.365 per share to $0.380 per share.
 
In November 2016, the Company's board of directors authorized a share repurchase program allowing the Company to purchase up to $1.0 billion of its outstanding shares of common stock, subject to market conditions. During the nine months ended June 30, 2018, the Company purchased 3.8 million shares of its common stock for a total of $325.4 million, which included $25.0 million of June 2018 purchases that cash settled in July 2018. As of June 30, 2018, the Company had $463.5 million of availability remaining under the November 2016 share repurchase program.
 
Basic earnings per share is computed by dividing net income attributable to AmerisourceBergen Corporation by the weighted average number of shares of common stock outstanding during the periods presented. Diluted earnings per share is computed by dividing net income attributable to AmerisourceBergen Corporation by the weighted average number of shares of common stock outstanding, plus the dilutive effect of stock options, restricted stock, and restricted stock units during the periods presented.
 
 
Three months ended
June 30,
 
Nine months ended
June 30,
(in thousands)
 
2018
 
2017
 
2018
 
2017
Weighted average common shares outstanding - basic
 
218,569

 
218,676

 
218,698

 
218,336

Dilutive effect of stock options, restricted stock, and restricted stock units
 
2,191

 
3,197

 
2,599

 
3,362

Weighted average common shares outstanding - diluted
 
220,760


221,873


221,297


221,698


 
The potentially dilutive stock options, restricted stock, and restricted stock units that were antidilutive for the three and nine months ended June 30, 2018 were 3.1 million and 3.2 million, respectively. The potentially dilutive stock options, restricted stock, and restricted stock units that were antidilutive for the three and nine months ended June 30, 2017 were 3.7 million and 4.3 million, respectively.